In addition, tumor growth was found to be reduced by 97.5% in response to Pt-Mal-LHRH 20 mg/kg treatment, whereas carboplatin 20 mg/kg only led to a 14.8% reduction (Fig 2A). Here, GNRH1 is linked to neoplasm.